Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The ferroquine antimalarial conundrum: redox activation and reinvasion inhibition.

Dubar F, Slomianny C, Khalife J, Dive D, Kalamou H, Guérardel Y, Grellier P, Biot C.

Angew Chem Int Ed Engl. 2013 Jul 22;52(30):7690-3. doi: 10.1002/anie.201303690.

PMID:
23765846
2.

Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.

Supan C, Mombo-Ngoma G, Dal-Bianco MP, Ospina Salazar CL, Issifou S, Mazuir F, Filali-Ansary A, Biot C, Ter-Minassian D, Ramharter M, Kremsner PG, Lell B.

Antimicrob Agents Chemother. 2012 Jun;56(6):3165-73. doi: 10.1128/AAC.05359-11.

3.

Opening up the advantages of the ruthenocenic bioprobes of ferroquine: distribution and localization in Plasmodium falciparum-infected erythrocytes.

Biot C, Dubar F, Khalife J, Slomianny C.

Metallomics. 2012 Aug;4(8):780-3. doi: 10.1039/c2mt20063e.

PMID:
22700030
4.

The antimalarial ferroquine: from bench to clinic.

Biot C, Nosten F, Fraisse L, Ter-Minassian D, Khalife J, Dive D.

Parasite. 2011 Aug;18(3):207-14. Review.

5.

Ferroquine: welcome to the next generation of antimalarials.

Wells TN, Hooft van Huijsduijnen R.

Lancet Infect Dis. 2015 Dec;15(12):1365-6. doi: 10.1016/S1473-3099(15)00148-6. No abstract available.

PMID:
26342426
6.

In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border.

Barends M, Jaidee A, Khaohirun N, Singhasivanon P, Nosten F.

Malar J. 2007 Jun 27;6:81.

7.

Investigation of the redox behavior of ferroquine, a new antimalarial.

Chavain N, Vezin H, Dive D, Touati N, Paul JF, Buisine E, Biot C.

Mol Pharm. 2008 Sep-Oct;5(5):710-6. doi: 10.1021/mp800007x.

PMID:
18563912
8.

In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.

Kreidenweiss A, Kremsner PG, Dietz K, Mordmüller B.

Am J Trop Med Hyg. 2006 Dec;75(6):1178-81.

9.

The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance.

Dubar F, Egan TJ, Pradines B, Kuter D, Ncokazi KK, Forge D, Paul JF, Pierrot C, Kalamou H, Khalife J, Buisine E, Rogier C, Vezin H, Forfar I, Slomianny C, Trivelli X, Kapishnikov S, Leiserowitz L, Dive D, Biot C.

ACS Chem Biol. 2011 Mar 18;6(3):275-87. doi: 10.1021/cb100322v.

PMID:
21162558
10.

Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay.

Eyase FL, Akala HM, Johnson JD, Walsh DS.

Am J Trop Med Hyg. 2011 Dec;85(6):984-8. doi: 10.4269/ajtmh.2011.11-0260.

11.

In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon.

Atteke C, Ndong JM, Aubouy A, Maciejewski L, Brocard J, Lébibi J, Deloron P.

J Antimicrob Chemother. 2003 Apr;51(4):1021-4.

12.

In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum.

Daher W, Pelinski L, Klieber S, Sadoun F, Meunier V, Bourrié M, Biot C, Guillou F, Fabre G, Brocard J, Fraisse L, Maffrand JP, Khalife J, Dive D.

Drug Metab Dispos. 2006 Apr;34(4):667-82.

13.
14.

Analysis of immune response patterns in naïve and Plasmodium berghei-infected young rats following a ferroquine treatment.

Pierrot C, Lafitte S, Dive D, Fraisse L, Brocard J, Khalife J.

Int J Parasitol. 2005 Dec;35(14):1601-10.

PMID:
16140302
15.

Antimalarial 4-aminoquinolines: mode of action and pharmacokinetics.

Pussard E, Verdier F.

Fundam Clin Pharmacol. 1994;8(1):1-17. Review.

PMID:
8181791
16.

Ferrocene-pyrimidine conjugates: Synthesis, electrochemistry, physicochemical properties and antiplasmodial activities.

Chopra R, de Kock C, Smith P, Chibale K, Singh K.

Eur J Med Chem. 2015 Jul 15;100:1-9. doi: 10.1016/j.ejmech.2015.05.043.

PMID:
26057222
17.

Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial.

Dive D, Biot C.

ChemMedChem. 2008 Mar;3(3):383-91. Review. No abstract available.

PMID:
17806092
18.

Ferroquine and its derivatives: new generation of antimalarial agents.

Wani WA, Jameel E, Baig U, Mumtazuddin S, Hun LT.

Eur J Med Chem. 2015 Aug 28;101:534-51. doi: 10.1016/j.ejmech.2015.07.009. Review.

PMID:
26188909
19.

Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission.

Mustfa K, Landau I, Chabaud AG, Chavatte JM, Chandenier J, Duong TH, Richard-Lenoble D.

Sante. 2011 Jul-Sep;21(3):133-42. doi: 10.1684/san.2011.0261.

20.

The Plasmodium falciparum-infected red blood cell.

Tilley L, Dixon MW, Kirk K.

Int J Biochem Cell Biol. 2011 Jun;43(6):839-42. doi: 10.1016/j.biocel.2011.03.012. Review.

PMID:
21458590
Items per page

Supplemental Content

Support Center